Immix Biopharma, Inc. (IMMX)
9.22
+0.22
(+2.44%)
USD |
NASDAQ |
Jun 01, 16:00
9.22
0.00 (0.00%)
After-Hours: 20:00
Immix Biopharma Market Cap : 501.67M for June 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 25.34M |
| Relay Therapeutics, Inc. | 3.111B |
| Annexon, Inc. | 911.78M |
| ACADIA Pharmaceuticals, Inc. | 3.686B |
| Alnylam Pharmaceuticals, Inc. | 39.48B |
Market Cap Related Metrics
| PEG Ratio | -0.3685 |
| Price to Book Value | 5.946 |
| Price | 9.22 |
| Earnings Yield | -9.98% |
| PEGY Ratio | -0.3685 |